Commission on Malaria

Commission on Malaria. The Commission on Malaria is a specialized body dedicated to coordinating and advancing the global fight against malaria, a mosquito-borne infectious disease caused by Plasmodium parasites. It typically operates under the auspices of or in close partnership with major international health organizations, focusing on policy, research, and the implementation of control strategies. Its work is critical in regions with high disease burden, particularly in Sub-Saharan Africa and parts of Asia.

History

The establishment of the Commission on Malaria followed growing international recognition of the disease's devastating impact, particularly after initiatives like the World Health Organization's Global Malaria Eradication Programme launched in the mid-20th century. Its formation was often influenced by landmark reports and declarations, such as those from the Roll Back Malaria Partnership and the United Nations Millennium Development Goals. Key figures in tropical medicine and public health, including researchers affiliated with institutions like the London School of Hygiene & Tropical Medicine and the Centers for Disease Control and Prevention, have historically shaped its mandate and evolution.

Objectives and functions

The primary objective is to reduce the global incidence of and mortality from malaria through evidence-based policy and coordinated action. Core functions include synthesizing scientific research on topics like artemisinin-based combination therapies and insecticide-treated bed nets to formulate guidelines. It also monitors epidemiological trends, often collaborating with entities like the World Bank and the Global Fund to Fight AIDS, Tuberculosis and Malaria to secure and direct funding. A further key function is to provide technical assistance to national malaria control programs in endemic countries such as Nigeria and the Democratic Republic of the Congo.

Key activities and programs

Key activities revolve around supporting the scale-up of proven interventions, including the distribution of long-lasting insecticidal nets and promoting indoor residual spraying with compounds like DDT or alternatives. The commission often oversees or contributes to large-scale operational research projects, such as trials for the RTS,S malaria vaccine developed by GSK and PATH. It facilitates training workshops for healthcare workers in endemic regions and engages in advocacy at high-level forums like the World Health Assembly and the African Union to maintain political commitment.

Organizational structure

The organizational structure typically includes a secretariat headed by an executive director, supported by technical advisors specializing in areas like entomology, pharmacology, and health economics. It often functions through expert working groups or committees that focus on specific challenges, such as antimalarial drug resistance in the Greater Mekong Subregion. Governance usually involves a steering committee with representation from partner organizations, which may include the Bill & Melinda Gates Foundation, UNICEF, and national ministries of health from member states.

Impact and achievements

The commission's work has contributed to significant milestones in malaria control, including documented reductions in prevalence in several countries as reported in publications like The Lancet. Its advocacy and technical guidance have helped accelerate the adoption of rapid diagnostic tests and improve surveillance systems, aiding the efforts of organizations like the President's Malaria Initiative. Achievements also include playing a role in the pilot implementation of the RTS,S vaccine in Ghana, Kenya, and Malawi, marking a historic step in immunization against the disease.

Challenges and criticisms

Major challenges include the persistent threat of insecticide resistance in Anopheles mosquito vectors and parasite resistance to key drugs like artemisinin. Critics have sometimes pointed to potential overlaps with the mandates of other bodies like the World Health Organization's Global Malaria Programme, questioning administrative efficiency. Operational challenges involve navigating complex health systems in conflict-affected areas such as South Sudan and ensuring sustainable financing beyond cycles of grants from major donors like the Global Fund.